Antibody Titers Before and After a Third Dose of the SARS-Co

This study assesses antispike (anti-S) IgG antibody titers before and after a third BNT162b2 dose (booster) in individuals aged 60 years and older in Israel.

Related Keywords

Israel , Israeli , Petah Tikva , Halozyme Incyte , Salomonm Stemmer , Avital Bareket Samish , Jodyw Zylke , Kristin Walter , Bioinsight Ltd , Teva Pharmaceuticals , Pfizer , Astrazeneca , Davidoff Cancer Center , Abbott Laboratories , Israeli Ministry Of Health , Rabin Medical Center , Tel Aviv University , Israeli Ministry , Deputy Editor , Belinson Hospital , Sackler Faculty , Interest Disclosures , Clovis Oncology , Sharing Statement ,